Minidiab 5mg 2x15Tab (CP)
Item requires a valid prescription
Glipizide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
As for any hypoglycemic agent, dosage must be adapted for each individual case.The recommended starting dose is 5 mg/day, given before breakfast or the mid-day meal. Elderly patients and other patients at risk for hypoglycemia may be started on 2.5 mg.
You should not use Minidiab if you:
allergic to glipizide or any other sulphonylurea or any ingredients in Minidiab tablets
pregnant may become pregnant or breast-feeding - have type I diabetes mellitus (insulin dependent diabetes mellitus), diabetic ketoacidosis, or diabetic coma - have severe kidney, liver or thyroid disease
nausea, vomiting, stomach pain, diarrhea, constipation.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.